
ProteinQure is a biotechnology company specializing in the design of novel peptide-based drug delivery systems. Leveraging its proprietary ProteinStudio™ platform, which utilizes advanced computational tools, AI, and molecular simulations, the company creates highly targeted, effective treatments with the potential to transform patient care. ProteinQure's approach focuses on tissue-specific delivery of therapeutic payloads, aiming to optimize efficacy and minimize side effects. They are developing a pipeline of assets, including a Sortilin delivery system, and highlight advantages such as tissue specificity, re-dosability, tolerability, and flexible building blocks for their peptide designs. The company collaborates with industry leaders and emphasizes its multidisciplinary team of scientists.

ProteinQure is a biotechnology company specializing in the design of novel peptide-based drug delivery systems. Leveraging its proprietary ProteinStudio™ platform, which utilizes advanced computational tools, AI, and molecular simulations, the company creates highly targeted, effective treatments with the potential to transform patient care. ProteinQure's approach focuses on tissue-specific delivery of therapeutic payloads, aiming to optimize efficacy and minimize side effects. They are developing a pipeline of assets, including a Sortilin delivery system, and highlight advantages such as tissue specificity, re-dosability, tolerability, and flexible building blocks for their peptide designs. The company collaborates with industry leaders and emphasizes its multidisciplinary team of scientists.